Tobramycin disposition in the rat lung following airway administration

Journal of Pharmacology and Experimental Therapeutics

Volumn 347, Issue 2, 2013, Pages 318-324

  Li, Min ^a   Byron, Peter R ^a  

^a VIRGINIA COMMONWEALTH UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUORESCEIN; MANNITOL; TOBRAMYCIN;

ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; CONTROLLED STUDY; DRUG ABSORPTION; DRUG BINDING; DRUG DISPOSITION; DRUG RELEASE; DRUG TISSUE LEVEL; LUNG PARENCHYMA; MALE; NONHUMAN; PRIORITY JOURNAL; RAT; RESPIRATORY DRUG ADMINISTRATION;

ABSORPTION; ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; DOSE-RESPONSE RELATIONSHIP, DRUG; EQUIPMENT DESIGN; LUNG; MALE; MODELS, BIOLOGICAL; PERFUSION; RATS; RATS, SPRAGUE-DAWLEY; TISSUE DISTRIBUTION; TOBRAMYCIN;

EID: 84886079772     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.113.207415     Document Type: Article

References (36)

1. Bottari F, Colo GD, Nannipieri E, Saettone M.F., and Serafini MF (1975) Evaluation of a dynamic permeation technique for studying drug-macromolecule interactions. J Pharm Sci 64:946-949.
2. Brown RA, Jr and Schanker LS (1983) Absorption of aerosolized drugs from the rat lung. Drug Metab Dispos 11:355-360.
3. Byron PR and Niven RW (1988) A novel dosing method for drug administration to the airways of the isolated perfused rat lung. J Pharm Sci 77:693-695.
4. Byron PR, Roberts NS, and Clark AR (1986) An isolated perfused rat lung preparation for the study of aerosolized drug deposition and absorption. J Pharm Sci 75: 168-171.
5. Chuchalin A, Amelina E, and Bianco F (2009) Tobramycin for inhalation in cystic fibrosis: Beyond respiratory improvements. Pulm Pharmacol Ther 22:526-532.
6. Crapo JD, Young SL, Fram E.K., Pinkerton KE, Barry BE, and Crapo RO (1983) Morphometric characteristics of cells in the alveolar region of mammalian lungs. Am Rev Respir Dis 128:S42-S46.
7. Cryan SA, Sivadas N, and Garcia-Contreras L (2007) In vivo animal models for drug delivery across the lung mucosal barrier. Adv Drug Deliv Rev 59:1133-1151.
8. Gibaldi M and Perrier D (1975) Pharmacokinetics, Marcel Dekker, New York.
9. Hashimoto M, Higashi T, Isomoto A., Uozumi M, and Okumura A (1984) A dynamic dialysis method for studying protein-ligand binding using chromatographic theory. Anal Biochem 137:344-350.
10. Hiel H, Erre JP, Aurousseau C, Bouali R., Dulon D, and Aran JM (1993) Gentamicin uptake by cochlear hair cells precedes hearing impairment during chronic treatment. Audiology 32:78-87.
11. Hiji Y, Sugiyama M, and Yamada M (1978) Dynamic dialysis utilizing a hollow fibre unit as a rapid method for studying protein binding. Arch Int Physiol Biochim 86: 531-541.
12. Jaresko GS and Alexander DP (1995) Respiratory Tract Infections, in Applied Therapeutics (Young LY ed) pp 58-114, Applied Therapeutics, Inc., Vancouver, WA.
13. Just M and Habermann E (1977) The renal handling of polybasic drugs. 2. In vitro studies with brush border and lysosomal preparations. Naunyn Schmiedebergs Arch Pharmacol 300:67-76.
14. Lenney W, Edenborough F, Kho P., and Kovarik JM (2011) Lung deposition of inhaled tobramycin with eFlow rapid/LC Plus jet nebuliser in healthy and cystic fibrosis subjects. J Cyst Fibros 10:9-14.
15. Li M and Byron PR (2012) Pulmonary bioavailability of aerosolized tobramycin in humans, in Respiratory Drug Delivery 3:887-892, at http://www.rddonline.com/
16. Meyer MC and Guttman DE (1968) Novel method for studying protein binding. J Pharm Sci 57:1627-1629.
17. Meyer MC and Guttman DE (1970) Dynamic dialysis as a method for studying protein binding. II. Evaluation of the method with a number of binding systems. J Pharm Sci 59:39-48.
18. Mingeot-Leclercq MP and Tulkens PM (1999) Aminoglycosides: nephrotoxicity. Antimicrob Agents Chemother 43:1003-1012.
19. Nagai J and Takano M (2004) Molecular aspects of renal handling of aminoglycosides and strategies for preventing the nephrotoxicity. Drug Metab Pharmacokinet 19: 159-170.
20. Niven RW and Byron PR (1988) Solute absorption from the airways of the isolated rat lung. I. The use of absorption data to quantify drug dissolution or release in the respiratory tract. Pharm Res 5:574-579.
21. Niven RW, Rypacek F, and Byron PR (1990) Solute absorption from the airways of the isolated rat lung. III. Absorption of several peptidase-resistant, synthetic polypeptides: poly-(2-hydroxyethyl)-aspartamides. Pharm Res 7:990-994.
22. Patton JS, Fishburn CS, and Weers JG (2004) The lungs as a portal of entry for systemic drug delivery. Proc Am Thorac Soc 1:338-344.
23. Pedersen PV, Crooks MJ, and Brown KF (1977) Method of obtaining drug-macromolecule binding parameters directly from dynamic dialysis data. J Pharm Sci 66:1458-1461.
24. Phillips I and Shannon KP (1997) Aminoglycosides and Aminocyclitols, in Antibiotic and Chemotherapy (O'Grady F and Lambert HP eds) pp 164-201, Churchill Livingstone, New York, NY.
25. Plopper CG (1983) Comparative morphologic features of bronchiolar epithelial cells. The Clara cell. Am Rev Respir Dis 128:S37-S41.
26. Sakagami M (2006) In vivo, in vitro and ex vivo models to assess pulmonary absorption and disposition of inhaled therapeutics for systemic delivery. Adv Drug Deliv Rev 58:1030-1060.
27. Sakagami M, Byron PR, Venitz J, and Rypacek F (2002) Solute disposition in the rat lung in vivo and in vitro: determining regional absorption kinetics in the presence of mucociliary escalator. J Pharm Sci 91:594-604.
28. Schentag JJ, Lasezkay G, Cumbo T.J., Plaut ME, and Jusko WJ (1978) Accumulation pharmacokinetics of tobramycin. Antimicrob Agents Chemother 13:649-656.
29. Sparrow NA, Russell AE, and Glasser L (1982) An automated continuous-flow dynamic dialysis technique for investigating protein-ligand binding. Anal Biochem 123:255-264.
30. Stepanyan RS, Indzhykulian AA, Vélez-Ortega AC, Boger ET, Steyger PS, Friedman TB, and Frolenkov GI (2011) TRPA1-mediated accumulation of aminoglycosides in mouse cochlear outer hair cells. J Assoc Res Otolaryngol 12:729-740.
31. Sun JZ, Byron PR, and Rypacek F (1999) Solute absorption from the airways of the isolated rat lung. V. Charge effects on the absorption of copolymers of N(2-hydroxyethyl)-DL-aspartamide with DL-aspartic acid or dimethylaminopropyl- DL-aspartamide. Pharm Res 16:1104-1108.
32. Todd JH and Hottendorf GH (1995) Renal brush border membrane vesicle aminoglycoside binding and nephrotoxicity. J Pharmacol Exp Ther 274:258-263.
33. United States Pharmacopiea Convention (2007) United States Pharmacopeia and National Formulary (USP 30-NF 25), United States Pharmacopeia Convention, Rockville, MD.
34. Valcke YJ and Pauwels RA (1991) Pharmacokinetic evaluation of tobramycin in the alveolar lining fluid of the rat after endotracheal administration. Am Rev Respir Dis 144:1199-1201.
35. Vozeh S, Spring P, Wenk M., and Follath F (1979) Changes in the apparent half life of gentamicin and tobramycin without detectable changes in creatinine clearance. Br J Clin Pharmacol 7:629-631.
36. Winslade NE, Adelman MH, Evans E.J., and Schentag JJ (1987) Single-dose accumulation pharmacokinetics of tobramycin and netilmicin in normal volunteers. Antimicrob Agents Chemother 31:605-609.